![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Friday, September 27, 2013 7:00:26 AM
The can raise up to $8mm and will have funding now through 2015. In my opinion; they will be able to accelerate both the MANF and LymPro programs on a more aggressive basis. Overall, Jason Napodano has been looking for the cash raise that becomes a game changer for the company. Moreover, the ability to uplist (to a National exchange.. if the price trades over $.10 is an added bonus. Of course; the dilutive nature of any financing deal is a necessary evil.
Bottom line: the really good news (that is due out and coming) was held back due to the financing deals completed recently (a reason for everything). Expect the PR machine to light up next week!!!
News link:
http://finance.yahoo.com/news/amarantus-bioscience-holdings-announces-2nd-103554307.html
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM